The Centers for Disease Control and Prevention (CDC) and several state and local health departments are testing for Zika virus, and recently, the CDC has released revised Zika virus laboratory testing guidance. During a recent Clinician Outreach and Communication Activity (COCA) call, held on December 1, clinicians from around the country learned about the updated recommendations in CDC’s Guidance for U.S. Laboratories Testing for Zika Virus Infection and received a better understanding of their role in testing specimens collected from patients.
Matt Binnicker, Ph.D., Director of the Clinical Virology Laboratory in the Division of Clinical Microbiology at Mayo Clinic, was a presenter on the COCA call. Dr. Binnicker presented a segement on "Diagnostic Testing for Zika Virus in Clinical Laboratories." He discussed how controlling Zika is a team effort among providers, public health, and clinical laboratories. He also referenced various diagnostic assays available for the Zika virus, and highlighted cases in which the tests may be used.
The webinar has been archived on the CDC's website with access to the slides, transcript, audio, and video recordings.